###begin article-title 0
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 67 76 67 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 279 284 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 138 146 <span type="species:ncbi:9606">patients</span>
The gene MICA encodes the protein major histocompatibility complex class I polypeptide-related sequence A. It is expressed in synovium of patients with rheumatoid arthritis (RA) and its implication in autoimmunity is discussed. We analyzed the association of genetic variants of MICA with susceptibility to RA.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 297 306 297 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 431 440 431 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Initially, 300 French Caucasian individuals belonging to 100 RA trio families were studied. An additional 100 independent RA trio families and a German Caucasian case-control cohort (90/182 individuals) were available for replication. As MICA is situated in proximity to known risk alleles of the HLA-DRB1 locus, our analysis accounted for linkage disequilibrium either by analyzing the subgroup consisting of parents not carrying HLA-DRB1 risk alleles with transmission disequilibrium test (TDT) or by implementing a regression model including all available data. Analysis included a microsatellite polymorphism (GCT)n and single-nucleotide polymorphisms (SNPs) rs3763288 and rs1051794.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 174 176 174 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 268 270 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 476 478 476 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 535 537 535 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 668 670 668 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 726 728 726 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 801 802 801 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 802 803 802 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 802 803 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>2</sup></italic>
###xml 828 833 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 861 862 861 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>2</sup></italic>
In contrast to the other investigated polymorphisms, the non-synonymously coding SNP MICA-250 (rs1051794, Lys196Glu) was strongly associated in the first family cohort (TDT: P = 0.014; regression model: odds ratio [OR] 0.46, 95% confidence interval [CI] 0.25 to 0.82, P = 0.007). Although the replication family sample showed only a trend, combined family data remained consistent with the hypothesis of MICA-250 association independent from shared epitope (SE) alleles (TDT: P = 0.027; regression model: OR 0.56, 95% CI 0.38 to 0.83, P = 0.003). We also replicated the protective association of MICA-250A within a German Caucasian cohort (OR 0.31, 95% CI 0.1 to 0.7, P = 0.005; regression model: OR 0.6, 95% CI 0.37 to 0.96, P = 0.032). We showed complete linkage disequilibrium of MICA-250 (D' = 1, r2= 1) with the functional MICA variant rs1051792 (D' = 1, r2= 1). As rs1051792 confers differential allelic affinity of MICA to the receptor NKG2D, this provides a possible functional explanation for the observed association.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 101 110 101 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
We present evidence for linkage and association of MICA-250 (rs1051794) with RA independent of known HLA-DRB1 risk alleles, suggesting MICA as an RA susceptibility gene. However, more studies within other populations are necessary to prove the general relevance of this polymorphism for RA.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 712 721 712 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 780 789 780 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1023 1032 1023 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1166 1175 1166 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1227 1236 1227 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1381 1382 1381 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1419 1428 1419 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1479 1480 1479 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1623 1624 1623 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Rheumatoid arthritis (RA) is a common autoimmune disease characterized by chronic inflammatory changes of joints and inner organs. It is estimated that at least 50% of the risk to develop RA is determined by genetic factors [1]. Considerable efforts have been made to elucidate these genetic factors to better understand the disease. However, even after the advent of genome-wide association studies, only somewhat more than half of the estimated genetic risk for RA has been assigned to specific genetic determinants [2]. There is strong evidence [3-5]. that additional genetic risk factors reside within a genomic region containing the strongest known genetic determinants of RA susceptibility, alleles of the HLA-DRB1 gene. Identification of additional risk factors within the HLA-DRB1 gene region is complicated by the extraordinarily high local linkage disequilibrium (LD): Standard association analyses of genetic variants in candidate gene and genome-wide association studies are prone to confounding due to LD with HLA-DRB1 alleles. Successful identification of additional genetic risk factors in this region needs to account for risk conferred by different HLA-DRB1 alleles. Within the shared epitope (SE) hypothesis, HLA-DRB1 alleles *0101, *0102, *0401, *0404, *0405, *0408, and *1001 are most commonly reported to be associated with risk for RA in European Caucasians [6]. Recently, a new classification of HLA-DRB1 alleles was proposed by du Montcel and colleagues [7], taking into account risk-modifying effects of neighboring amino acids. This classification emerged as especially reproducible and reliable [8].
###end p 11
###begin p 12
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 50 59 50 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 451 452 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 651 652 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 653 655 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 727 729 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 811 813 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 836 841 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
MICA is located within the same genomic region as HLA-DRB1 (Figure 1). It encodes the protein major histocompatibility complex class I polypeptide-related sequence A. This protein interacts with the C-type lectin activatory receptor NKG2D (also known as KLRK1) found on natural killer cells, gammadelta T cells, and certain subgroups of alphabeta T cells. MICA-NKG2D interaction is believed to be important for eliminating infected or tumorous cells [9]. This interaction is also described to increase inflammatory cytokine production and proliferation of a certain subset of T cells. In consequence, implications in autoimmunity have been discussed [9-12]. MICA is expressed in RA synovium but not in osteoarthritis synovium [12]. Local NKG2D expression is induced by tumor necrosis factor and interleukin-15 [12]. These findings make MICA an interesting candidate gene for association studies in RA.
###end p 12
###begin p 13
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 33 42 33 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 136 145 136 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 295 304 295 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Location of MICA relative to the HLA-DRB1 locus. Despite a distance of more than one megabase from the rheumatoid arthritis risk factor HLA-DRB1 in the major histocompatibility complex (MHC) class II region, there is considerable linkage disequilibrium between markers in both genes. Therefore, HLA-DRB1 status must be considered for interpretation of genetic association data.
###end p 13
###begin p 14
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 526 535 526 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
The highly polymorphic gene MICA (122 frequency-validated single-nucleotide polymorphisms [SNPs] in SNP database [dbSNP] build 129) was investigated in various RA association studies in different populations. For several SNPs and for a microsatellite marker, associations with protection or risk were shown [4,13-17]. Results for different MICA variants were not conclusive but point toward association with RA. Heterogeneity between results of these studies may be due at least partially to confounding of results by LD with HLA-DRB1 alleles.
###end p 14
###begin p 15
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 83 92 83 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 282 291 282 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 420 429 420 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 532 541 532 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 800 809 800 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 842 843 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 994 1003 994 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 507 514 <span type="species:ncbi:9606">patient</span>
###xml 921 928 <span type="species:ncbi:9606">patient</span>
###xml 1027 1035 <span type="species:ncbi:9606">patients</span>
Some studies reported association analyses without controlling for LD of MICA with HLA-DRB1 alleles at all [14,17]. This makes a conclusion about an independent association of MICA intricate. If association analysis is done under the condition of no significant LD between MICA and HLA-DRB1 alleles [16], the problem prevails: Even weak, non-significant LD may bias MICA association analysis since effect sizes of known HLA-DRB1 risk alleles are considerably large. Other authors restricted analysis to the patient subgroup without HLA-DRB1 risk alleles, ignoring large parts of the data [13]. Alternatively, stratification of data in SE and non-SE subgroups ignores variance of the individual risk of SE alleles within the SE subgroup [15]. In a recent study, case-control pairs were matched 1:1 by HLA-DRB1 genotype to control confounding [4]. However, as a disadvantage of this method, large proportions of typical RA patient and control collections are excluded from analysis since certain HLA-DRB1 genotypes are common in patients but rare in controls and vice versa.
###end p 15
###begin p 16
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 163 172 163 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 247 256 247 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Our aim was to investigate the role of DNA polymorphisms of MICA in French Caucasian RA family trios and in a German Caucasian case-control cohort. Confounding by HLA-DRB1 risk alleles was controlled by analysis of the subgroup negative for known HLA-DRB1 risk alleles and by logistic regression including all data.
###end p 16
###begin title 17
Materials and methods
###end title 17
###begin title 18
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 18
###begin p 19
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 315 323 <span type="species:ncbi:9606">patients</span>
###xml 680 688 <span type="species:ncbi:9606">patients</span>
###xml 919 927 <span type="species:ncbi:9606">patients</span>
We analyzed 600 French Caucasian individuals belonging to 200 families grouped in two cohorts of 100 family trios. Characteristics (gender, age at onset, disease duration, erosions, seropositivity, and SE) as well as details on DNA preparation were described previously [18]. Seventy-six percent of French RA index patients were positive for anti-cyclic citrullinated peptide antibodies (CCP+). For case-control analysis, 272 German Caucasians were analyzed. Controls were 182 healthy blood donors (mean age +/- standard deviation [SD] was 50 +/- 7 years, and 80% were female) from the Institute of Transfusion Medicine, University Hospital Leipzig, Germany, and cases were 90 RA patients from the Medical Clinic IV, University Hospital Leipzig, Germany, with the following characteristics: mean age (+/- SD) at disease onset was 47.1 +/- 15.7 years, mean (+/- SD) disease duration was 26.7 +/- 20.5 years, 92% were RA patients seropositive for rheumatoid factor, and 78% were female. All individuals provided informed consent, and the ethics committees of Hopital Bicetre (Kremlin-Bicetre, AP-HP, France) and of the University of Leipzig (Leipzig, Germany) approved the study.
###end p 19
###begin title 20
Genotyping
###end title 20
###begin p 21
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 512 516 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 659 663 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 789 793 789 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 980 982 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 983 985 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
We investigated three polymorphisms spanning MICA for association with RA. For SNP selection, we required frequency validation, a map weight of 1, and a minor allele frequency exceeding 5% in Caucasians. Among 775 SNPs available within the MICA region in Ensemble version 24, 7 were frequency-validated and had a map weight of 1. Within the promoter region, defined as within 5 kb upstream of the start of the gene, we selected MICA-300 (rs3763288). According to TESS (Transcription Element Search System) [19], MICA-300 co-localizes with a binding site for the transcription factor ETV4. Within the coding region, we selected the non-synonymously coding SNP MICA-250 (rs1051794, Lys196Glu) as validation information for this variant was previously published [20,21]. In addition, variant MICA-210 (a trinucleotide repeat (GCT)n microsatellite polymorphism within the transmembrane domain) was selected as various associations of this variant with RA were reported previously [15-17,22].
###end p 21
###begin p 22
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 618 623 618 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICB</italic>
###xml 716 721 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 734 738 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICB</italic>
###xml 919 921 919 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1005 1007 1003 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1065 1067 1063 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Genotyping was done by applying single-base extension followed by mass spectrometry ('GenoSNIP') as described [23] but with the following modifications: polymerase chain reaction (PCR) and genotyping primers for MICA-210: CCTTTTTTTCAGGGAAAGTGC, CCTTACCATCTCCAGAAACTGC [22], and bioCCATGTTTCTGCTG(L)TGCTGCT; MICA-300: GGAAGGCTGTGCAGTAATCTAGG, TCCCTTTTCCAGCCTGCC, and bioCTGTGCAGT(L)ATCTAGGCTGAAGG; and MICA-250: AAGGTGATGGGTTCGGGAA, TCTAGCAGAATTGGAGGGAG [21], and bioCTCAGGAC(L)ACGCCGGATT. For the MICA-250 assay, a genotyping primer bioCTCCAGAG [L]TCAGACCTTGGC, differentiating between a paralogue sequence variant of MICA and MICB, was genotyped in 558 (63.8%) samples. This assay always indicated amplification of MICA and never of MICB. PCR products were checked by agarose gel electrophoresis for correct size and sufficient yield. Within the studied population, no Mendel error occurred. No significant departure (P </= 0.05) from Hardy-Weinberg equilibrium was observed in controls (French samples: P = 0.240 for non-transmitted chromosomes; German controls: P = 0.233; chi-square test with one degree of freedom).
###end p 22
###begin p 23
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 129 138 129 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 251 260 251 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
HLA-DRB1 was genotyped previously using sequence-specific PCR primers and hybridization of PCR products with probes specific for HLA-DRB1 alleles, as described for the French family sample [18] and the German case-control sample [24]. Distribution of HLA-DRB1 alleles can be found in the online supplement (Additional data file 1).
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 304 306 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
For association analysis, we chose a multistep approach. In a first cohort of 100 family trios, selected polymorphisms were tested for association with RA. Those showing nominal association at a significance level of 0.05 or below were tested in a second cohort of 100 French family trios. A decrease in P value in the combined French cohorts was taken as strong evidence in favor of association. These polymorphisms were further analyzed in a German Caucasian case-control cohort.
###end p 25
###begin p 26
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 147 156 147 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Haplotypes were estimated using the software HAPLORE (HAPLOtype REconstruction) [25]. For these estimations, data of SNPs located between MICA and HLA-DRB1 were included (rs1800629, rs909253, rs3093553, and rs3093562 for the second French cohort and additionally rs1043618, rs2075800, rs1799964, rs1800630, rs3093662, and rs3093664 for the first French cohort; data available online [26]). We successfully assigned haplotypes for 95% of all families (minimum posterior probability was 90% and mean posterior probability was greater than 99.9%).
###end p 26
###begin p 27
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 180 189 180 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
Transmission disequilibrium test (TDT) for association and linkage with RA was calculated as described by Spielman and colleagues [27]. For subgroup analyses, the subgroup without HLA-DRB1 risk alleles was defined by the absence of SE alleles. This is identical with allele L according to the classification by du Montcel and colleagues [7]. Derived haplotype information allowed identification of transmitted and non-transmitted chromosomes.
###end p 27
###begin p 28
###xml 131 140 131 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 886 895 886 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 985 990 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 1007 1016 1007 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1114 1123 1114 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1135 1140 1135 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 1176 1185 1176 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1275 1280 1275 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 1297 1299 1297 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1356 1361 1356 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 1414 1423 1414 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1481 1486 1481 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 1490 1498 1490 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 1606 1607 1606 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
###xml 764 772 <span type="species:ncbi:9606">children</span>
For conditional logistic regression analysis of families, LogXact (Cytel Inc., Cambridge, MA, USA) was used. Within this analysis, HLA-DRB1 allele classification was according to du Montcel and colleagues [7]. The S3P allele consisted of alleles *0101, *0102, *0404, *0405, *0408, and *1001, and the S2 allele consisted of *0401. We applied the convention that allele L denotes alleles S1, S3D, and X as the associated risk for RA of the latter three alleles was found to be of similar magnitude [7,8]. Of the index patients of all 200 French families, 53% and 45% contributed to allele groups S3P and S2, respectively. Twenty-one percent were homozygous for allele L. In regression analysis, we modeled the transmission probability of a haplotype toward affected children given the competitive haplotype of a parent. This method is known as conditional logistic regression. To include HLA-DRB1 alleles in the model, allele L was used as the reference group. To ensure independence of MICA association from HLA-DRB1 risk alleles, a likelihood ratio test (LRT) was done. Here, the likelihood of the model including HLA-DRB1 alleles and MICA was compared with a model including HLA-DRB1 alleles only. A significant increase of the model's likelihood that includes polymorphism MICA (that is, an LRT P value of less than 0.05) indicates an association of the MICA polymorphism independent of the known association of HLA-DRB1 alleles. Analogously, we checked for interactions between MICA and HLA-DRB1. Additional methodological remarks to this method are given in the online supplement (Additional data file 2).
###end p 28
###begin p 29
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 260 269 260 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 283 292 283 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 975 977 975 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Within the case-control cohort, haplotyping was not resolvable with the same accuracy as for the family cohorts. Hence, the logistic regression model was based on unphased data of MICA-250 and HLA-DRB1. It included all case-control individuals, accounting for HLA-DRB1 risk alleles. HLA-DRB1 classification according to du Montcel and colleagues [7] as described above was applied. Cases of the case-control cohort contributed to allele groups S3P (42%) and S2 (36%). Twenty-one percent were homozygous for allele L. Within the model, genotypes were coded (0, 1, and 2), with 2 coding for the homozygous minor allele. Thus, an additive model was implemented. LRTs were done similarly to the conditional logistic regression model described above. Multimarker LD analysis was done using the software MIDAS (Multiallelic Interallelic Disequilibrium Analysis Software) [28]. For the exact Mantel-Haenszel test, the software StatsDirect was used [29]. If not indicated otherwise, P values were not corrected for multiple testing.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
Association of MICA with rheumatoid arthritis within the first French family cohort
###end title 31
###begin p 32
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
We analyzed three polymorphisms within the gene MICA: MICA-300 (rs3763288) within the 5' region of the gene (promoter region), MICA-210 (trinucleotide repeat (GCT)n microsatellite polymorphism within the transmembrane domain), and MICA-250 (non-synonymously coding SNP, rs1051794, Lys196Glu).
###end p 32
###begin p 33
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1a</xref>
###xml 223 232 223 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 281 290 281 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1b</xref>
###xml 429 438 429 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 722 731 722 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1c</xref>
###xml 616 624 <span type="species:ncbi:9606">children</span>
In standard analysis (TDT without accounting for linkage with HLA-DRB1), we found significant undertransmission of MICA-250A in the first French family cohort (Table 1a). Our first strategy to account for potential LD with HLA-DRB1 was to restrict analysis to parents negative for HLA-DRB1 risk alleles. Here, we also found protective association of MICA-250A and RA (Table 1b). In our second strategy, we controlled for LD with HLA-DRB1 risk alleles by conditional logistic regression. MICA-250A again emerged as a protective factor as haplotypes including MICA-250A were significantly undertransmitted to affected children. The LRT was significant, demonstrating that MICA-250 is associated with RA independent of known HLA-DRB1 risk alleles (Table 1c).
###end p 33
###begin p 34
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
Association of MICA polymorphisms within the first French Caucasian family cohort
###end p 34
###begin p 35
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 207 216 207 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 280 289 280 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 329 331 329 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
aControls are non-transmitted alleles; bodds ratio of transmission of minor allele versus transmission of major allele as determined in logistic regression; clikelihood ratio test evaluating model including HLA-DRB1 alleles S2 and S3P and MICA-250 versus S2 and S3P only. For the HLA-DRB1 locus, allele L was used as reference. dP value corrected for multiple testing less than 0.05. CI, confidence interval; LD, linkage disequilibrium; TDT, transmission disequilibrium test.
###end p 35
###begin p 36
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
Association of MICA-250 with RA was stronger compared with association of other analyzed single markers (Table 1) and with three-marker haplotypes consisting of MICA-300, MICA-250, and MICA-210 (data not shown). Therefore, only MICA-250 was included in further validation studies within a second independent French Caucasian family cohort and a case-control cohort of German Caucasian origin.
###end p 36
###begin title 37
Association analysis within the second and combined first and second French family cohorts
###end title 37
###begin p 38
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 149 158 149 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 456 465 456 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1c</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2c</xref>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1049 1053 1049 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1062 1071 1062 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1212 1213 1212 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1303 1305 1303 1305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1341 1345 1341 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1433 1435 1433 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1448 1450 1448 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Within the second French family cohort, we found the same trend for protective association of MICA-250A with RA in standard analysis and in both the HLA-DRB1 risk allele-negative subgroup analysis and conditional logistic regression (Table 2). In combined analysis of both French family cohorts, association of MICA-250 was comparable with the association in the first French family cohort in standard analysis and in analysis of the subgroup negative for HLA-DRB1 risk alleles. In conditional logistic regression analysis, association in the combined cohorts was even more significant than in the first cohort alone (Tables 1c and 2c). Additionally, conditional logistic regression was done with a model in which S3P alleles were differentiated into three groups as described [8], accounting for potential differences in risk of these three groups for RA. Within this analysis, 79, 56, and 15 individuals contributed to the S3P*01, S3P*04, and S3P*10 alleles, respectively. This analysis gave similar results (data not shown). Interactions between MICA-250 and HLA-DRB1 alleles were not significant (data not shown). Full details of the regression model are shown in the online supplement (Additional data file 3). When the analysis of the combined first and second French cohorts was restricted to CCP+ RA, the protective association with MICA-250 A was also found (odds ratio [OR] 0.53, 95% confidence interval [CI] 0.33 to 0.83, P = 0.005; LRT P value = 0.003).
###end p 38
###begin p 39
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
Association of MICA polymorphism within the second and combined first and second French Caucasian family cohort
###end p 39
###begin p 40
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 207 216 207 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 280 289 280 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
aControls are non-transmitted alleles; bodds ratio of transmission of minor allele versus transmission of major allele as determined in logistic regression; clikelihood ratio test evaluating model including HLA-DRB1 alleles S2 and S3P and MICA-250 versus S2 and S3P only. For the HLA-DRB1 locus, allele L was used as reference. Effects of S2 and S3P alleles are presented in the online supplement (Additional data file 3). CI, confidence interval; LD, linkage disequilibrium; TDT, transmission disequilibrium test.
###end p 40
###begin title 41
Association analysis within the case-control cohort
###end title 41
###begin p 42
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3a</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3b</xref>
###xml 649 658 649 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3c</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 946 947 946 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
After demonstrating association of MICA with RA in French Caucasian family trios and its independence from HLA risk alleles, we analyzed the effect of MICA within a German Caucasian case-control cohort. Frequencies of MICA-250A were similar within the German and French populations (33% in controls). Again, we found protective association of MICA-250A with RA in standard analysis and within the subgroup of the case-control cohort not carrying SE alleles (Tables 3a and 3b). Logistic regression including all individuals demonstrated a significant protective effect as well. Significance in the LRT showed that this association was independent of HLA-DRB1 risk alleles (Table 3c). Details of the regression model are given in the online supplement (Additional data file 4). Additionally, conditional logistic regression was done with a model in which S3P alleles were differentiated into three groups (S3P*01, S3P*04, and S3P*10) as described [8], accounting for potential differences of these three groups in risk for RA. This analysis resulted in similar results (data not shown).
###end p 42
###begin title 43
Analysis of linkage disequilibrium
###end title 43
###begin p 44
###xml 245 253 245 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 329 331 329 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 385 394 385 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 546 554 546 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 562 566 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 698 700 698 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 716 719 716 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7 </sup>
###xml 787 795 787 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 826 828 826 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 891 899 891 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 1040 1044 1040 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1128 1132 1128 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1201 1203 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1345 1346 1345 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1346 1347 1346 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1346 1347 1346 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>2</sup></italic>
LD was analyzed within parents of the family cohorts and in the case-control cohort. As the German cohort was smaller, power to detect LD was decreased compared with power to detect LD within the French cohorts. Significant LD was found between HLA-DRB1-S3P and MICA-250A within parents of the French family cohorts (D' = +0.21, P < 0.001). Interestingly, this LD was positive between HLA-DRB1 risk alleles of subgroup S3P and the protective allele MICA-250A. In-depth analysis of the S3P group revealed that this resulted mainly from LD between HLA-DRB1*01 and MICA-250A, which was significant within parents of the family cohorts and cases from the case-control cohort (D' = +0.38 and +0.25 with P values of 2 x 10-7 and 0.047, respectively). Significant negative LD was found between HLA-DRB1-S2 and MICA-250A (D' = -0.51, P < 0.01) in French parents. No significant LD was found between HLA-DRB1-L within the family cohorts and individuals of the case-control cohort. In consequence, there was no significant correlation of carriage of MICA-250A with carriage of positive or negative SE status. LD was also analyzed between MICA-250 and rs1051792, another coding SNP with functional implications [30]. Within a representative sample of 182 French Caucasian and 181 German Caucasian cases and controls, both polymorphisms were in perfect LD (r2= 1, D' = 1).
###end p 44
###begin title 45
Representation of association analysis in all informative families controlling for linkage disequilibrium with HLA-DRB1
###end title 45
###begin p 46
###xml 137 146 137 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 300 309 300 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2b</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2c</xref>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 590 599 590 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 635 639 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 721 730 721 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 767 776 767 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 990 999 990 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1064 1068 1064 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1111 1115 1111 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1135 1144 1135 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1230 1234 1230 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1253 1262 1253 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1346 1350 1346 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1381 1385 1381 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1468 1469 1468 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1474 1483 1474 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1530 1539 1530 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1684 1688 1684 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1742 1746 1742 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1905 1906 1905 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1990 1994 1990 1994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 2051 2052 2051 2052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
An advantage of the conditional logistic regression approach is the integration of all data from all informative parents with respect to HLA-DRB1 and MICA. A single statistic reveals independent association of MICA-250. However, it is of interest to compare subgroup analysis of parents negative for HLA-DRB1 risk alleles with results of the regression model analyzing all data in detail (Tables 2b and 2c). A major difference is that the regression model additionally includes information of parents that are informative (that is, heterozygous) for MICA and that are also heterozygous for HLA-DRB1 risk alleles. How can the effect of MICA-250 on transmission be represented within these parents, devoid of the effect of HLA-DRB1 risk alleles? We propose to stratify HLA-DRB1 heterozygous parents according to their genotype. The transmission ratio under the null hypothesis of no association within these parents will differ from a 50/50 ratio reflecting the different risk levels of both HLA-DRB1 alleles. However, under the null hypothesis of no association of MICA-250, a two-marker haplotype consisting of MICA-250A and a certain HLA-DRB1 allele should have the same transmission rate as a two-marker haplotype consisting of MICA-250G and the same HLA-DRB1 allele. A deviation from this transmission rate represents an independent effect of MICA-250A quantifiable as an OR of MICA-250A transmission. As we applied the classification of du Montcel and colleagues [7] of HLA-DRB1 alleles, three different independent strata of HLA-DRB1 heterozygote parents exist: S3P/S2, S2/L, and S3P/L. Within all of these strata, we always found a decreased transmission of haplotypes carrying MICA-250A compared with the respective haplotype carrying MICA-250G (OR 0.33, 95% CI 0.02 to 5.11; OR 0.45, 95% CI 0.04 to 6.76; and OR 0.44, 95% CI 0.04 to 2.73, respectively, data of all families) (Additional data file 5). These observations are consistent with the significant protective association of MICA-250A revealed by conditional logistic regression (Table 2).
###end p 46
###begin p 47
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 717 719 717 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
When we additionally include data from parents homozygous for HLA-DRB1, we can analyze the OR of MICA-250A on transmission within these parents when we compare the observed transmission ratio of MICA-250A versus the expected transmission ratio (Additional data file 5). The expected transmission ratio is 50/50 (transmitted/non-transmitted) within these parents under the null hypothesis of no effect of MICA-250A. We now can combine information from all parents informative for MICA-250 by combining all four ORs of all four independent strata with exact Mantel-Haenszel methodology. This analysis confirmed a significant undertransmission of MICA-250A within all data of all families (OR 0.48, 95% CI 0.25 to 0.91, P = 0.02, Fisher exact test).
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 132 141 132 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 586 590 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 729 731 729 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 767 768 767 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 813 818 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 977 981 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
The aim of this study was to analyze the association of polymorphisms of MICA with risk for RA while controlling for the effects of HLA-DRB1 risk alleles. We successfully identified MICA-250A as a new independent marker associated with protection from RA susceptibility. We analyzed the association of three genetic variants of the gene MICA with susceptibility to RA in a French Caucasian family cohort. In validation studies (including an additional independent French Caucasian family cohort and a German Caucasian case-control cohort), we focused on the non-synonymously coding SNP MICA-250 (rs1051794, Lys196Glu). In our first French family cohort, this SNP presented with the strongest evidence for association in terms of P values and transmission rate (Table 1). Association of three-marker haplotypes of MICA with RA was not statistically significant. Therefore, we did not investigate haplotype association further. However, it cannot be excluded that association of MICA-250 with RA may be related to an unknown allelic variant in linkage with these haplotypes as haplotypes were inferred and have error margins.
###end p 49
###begin p 50
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 461 470 461 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2c</xref>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 626 635 626 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 683 692 683 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 845 849 845 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 900 909 900 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 951 955 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1009 1018 1009 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1071 1073 1071 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1092 1096 1092 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1125 1127 1125 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1218 1219 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
Within all combined French families, we found a significant undertransmission of MICA-250A in the TDT (Table 2). Therefore, we hereby provide evidence for linkage and association of MICA-250A with RA. This transmission analysis within trio families would not be affected by hidden population stratification. The association was also evident in conditional logistic regression analyses including all parents informative for MICA-250A and controlling for LD with HLA-DRB1 risk alleles (Table 2c). We did not find any indication that the observed protective effect of MICA-250A is especially present on the background of certain HLA-DRB1 alleles as interaction analyses of MICA-250 and HLA-DRB1 alleles in the regression model did not result in a significantly increased likelihood (data not shown). Additionally, detailed transmission analysis of MICA-250 within parents heterozygous or homozygous for HLA-DRB1 always resulted in a protective effect of MICA-250A of comparable magnitude irrespective of present HLA-DRB1 alleles (Additional data file 5). Analysis of the CCP+ subset showed that MICA-250 also associates with CCP+ RA. We confirmed the protective effect in a German Caucasian RA case-control cohort (Table 3), which indicates that the protective effect may not be restricted to the French Caucasian population alone.
###end p 50
###begin p 51
Case-control analysis in German Caucasians
###end p 51
###begin p 52
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 50 59 50 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 123 132 123 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
aLikelihood ratio test evaluating model including HLA-DRB1 alleles S2 and S3P and MICA-250 versus S2 and S3P only. For the HLA-DRB1 locus, allele L was used as reference. CI, confidence interval; LD, linkage disequilibrium; OR, odds ratio; RA, rheumatoid arthritis.
###end p 52
###begin p 53
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 172 181 172 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 420 429 420 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 537 546 537 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 683 692 683 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 741 745 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
###xml 515 523 <span type="species:ncbi:9606">patients</span>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
True association of MICA-250 with RA may be either feigned or masked by LD with known risk alleles. Therefore, we controlled for the separate contributions of MICA-250 and HLA-DRB1 alleles (S3P, S2, and L) to the observed effect by logistic regression. This allowed us to make use of data from all patients. However, it could be argued that this logistic regression might be affected by stratification of the individual HLA-DRB1 risk alleles in the groups used in the model. Hence, we also analyzed the subgroup of patients not carrying HLA-DRB1 risk alleles. Naturally, this subgroup does not contain data from all patients, but results are completely independent from the excluded HLA-DRB1 risk alleles. Both methods showed association of MICA-250A with RA.
###end p 53
###begin p 54
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 222 224 222 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 283 285 283 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 502 504 502 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 644 646 644 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 650 654 650 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 741 743 741 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 890 895 890 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 908 917 908 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1051 1059 1051 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 1069 1073 1069 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1132 1136 1132 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
In this context, it is of interest that, within all genome-wide association studies of RA published thus far, MICA-250 was found to be nominally associated: MICA-250A had a protective effect (OR 0.82, 95% CI 0.73 to 0.92, P = 0.0008, not corrected for genome-wide testing) within CCP+ RA in North American samples [31]. Similar findings result from a genome-wide study in a British RA cohort, in which data for an SNP in perfect LD with MICA-250 are available (rs1051792: OR 0.85, 95% CI 0.77 to 0.93, P = 0.0008, not corrected for genome-wide testing) [32]. These findings corroborate our observation of a protective effect of MICA-250A in CCP+ RA. MICA-250 was also associated with RA in a genome-wide study in a Spanish Caucasian cohort (P = 0.02, not corrected for genome-wide testing) [33]. In these genome-wide studies, association analysis was reported without controlling for LD of MICA alleles with HLA-DRB1 alleles. If LD structure in Caucasians in these genome-wide studies was similar to that in our study (that is, if positive LD between HLA-DRB1*0101 and MICA-250A was present), LD-corrected protective association of MICA-250A would be even stronger than reported.
###end p 54
###begin p 55
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 481 483 481 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 487 490 487 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-15</sup>
###xml 620 629 620 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 797 806 797 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 947 951 947 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 968 977 968 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1061 1065 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1082 1091 1082 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 1184 1188 1184 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 1316 1325 1316 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
The microsatellite polymorphism MICA-210 was studied in different populations. In Spanish [15] and Canadian [17] Caucasians, a protective effect was seen for allele MICA-210 6.0, whereas in Korean Asians [16], a protective effect was seen for MICA-210 9.0. No association of MICA-210 was seen in another Spanish Caucasian RA study [14]. None of these studies additionally analyzed MICA-250. However, in our study, strong LD between MICA-210 9.0 and MICA-250A was found (D' = 0.98, P < 10-15). Therefore, previous findings in Koreans are in accordance with our results. It is of interest that in this study only a single HLA-DRB1 RA susceptibility allele (*0405) predominates and no LD was found with *0405 and MICA-210 9.0, so that association analysis was hardly influenced by linkage with known HLA-DRB1 risk alleles. This is different from the Caucasian studies of the (GCT)n polymorphism: In our data, we found considerable LD between various MICA-210 alleles and HLA-DRB1 risk alleles (data not shown). We might speculate that complex LD structure between MICA-210 alleles and HLA-DRB1 alleles may at least partially explain differing results in Caucasian association studies of MICA-210 and RA. This is especially relevant as these studies either did not account at all or only partially accounted for LD with HLA-DRB1 alleles.
###end p 55
###begin p 56
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 190 199 190 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 467 475 467 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 502 510 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 552 556 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 851 855 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 912 920 912 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 927 935 927 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 986 988 986 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1001 1003 1001 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
In recently published work, HLA-DRB1-matched cases and controls were analyzed mainly in American Caucasians in order to identify genetic factors associated with CCP+ RA in addition to known HLA-DRB1 risk alleles [4]. Within the MICA genomic region, significant evidence for independent association with RA was found with a maximum association within HLA-C. This association was attributed to the risk of the A1-B8-DRB1*03 haplotype. Additionally, haplotypes carrying HLA-DRB1*0404 were described to be HLA-DRB1-independent risk factors. An analysis of MICA-250 was not reported in this study. There is evidence that association of MICA-250A in our data represents an additional disease-modifying factor, independent of described risk factors in the American Caucasian study. This evidence results from the observation that a protective association of MICA-250A is still observed when all parents carrying either HLA-DRB1*03 or HLA-DRB1*0404 were excluded (OR 0.56, 95% CI 0.35 to 0.89, P = 0.013; LRT P value = 0.009).
###end p 56
###begin p 57
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1294 1296 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1402 1406 1402 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 840 855 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1196 1201 <span type="species:ncbi:9606">women</span>
Generally, an observed association of a polymorphism with a phenotype need not arise from a direct functional effect of this polymorphism. It may simply originate from LD with a functional polymorphism. Therefore, it is of interest that the amino acid change due to MICA-250A (Lys196Glu) is predicted to influence Hsp70 binding [34]. Possibly even more relevant, SNP rs1051792, in perfect LD with MICA-250 in Caucasian HapMap data and in our data, was experimentally shown to influence binding of the NKG2D receptor [30]. Variant rs1051792A, corresponding to MICA-250A, was shown to strongly bind NKG2D. All other alleles lead to weaker binding. Several studies show that NKG2D expression is modulated by MICA expression level with consequences for immune reactions. Wiemann and colleagues [35] showed that persistent expression of MICA in transgenic mice resulted in downregulation of the amount of surface NKG2D. As a consequence, impaired immune reaction against bacteria and MICA-expressing tumors was observed. In a different context, Mincheva-Nilsson and colleagues [36] observed elevated levels of soluble MICA/MICB and a decreased level of NKG2D within maternal blood of healthy pregnant women. The authors showed that soluble MICA/MICB downregulates NKG2D levels and immune reactions [36]. Therefore, we speculate that an increased affinity of MICA to NKG2D, as must be present in carriers of MICA-250A, may have similar effects as increased expression of MICA, resulting in decreased NKG2D expression levels.
###end p 57
###begin p 58
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 715 719 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 332 337 <span type="species:ncbi:9606">women</span>
###xml 359 364 <span type="species:ncbi:9606">women</span>
In this context, the observation of RA remission during pregnancy may be of interest [37]. Apparently, decrease of NKG2D plays a central role in decreased immune response. During pregnancy, this seems to be triggered by increased levels of MICA/MICB and appears to contribute to tolerance against the fetus and disease remission in women with RA. As pregnant women show both downregulation of NKG2D due to increased MICA expression and remission of RA, it can be speculated that there may be a functional link between these two observations. If MICA-250A reports on stronger binding of MICA and if this also results in downregulation of NKG2D levels, this would be consistent with the observed protective effect of MICA-250A in our data. As there are many links between the innate and adaptive immune systems and involvement of pathogens in the initiation of RA is discussed (reviewed by Falgarone and colleagues [38]), differences in NKG2D levels induced by functional variants of MICA are not unlikely to have consequences for RA etiology.
###end p 58
###begin title 59
Conclusions
###end title 59
###begin p 60
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
###xml 115 124 115 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA </italic>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MICA</italic>
In summary, we present evidence for linkage and association of MICA-250 (rs1051794) with RA independently of known HLA-DRB1 association in French Caucasians and evidence for association in a German Caucasian population, suggesting MICA as an RA susceptibility gene. The association might be explained by functional evidence of rs1051792, an SNP in perfect LD with MICA-250. However, more studies within other populations are necessary to prove the general relevance of this polymorphism with RA.
###end p 60
###begin title 61
Abbreviations
###end title 61
###begin p 62
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
CCP+: positive for anti-cyclic citrullinated peptide antibodies; CI: confidence interval; LD: linkage disequilibrium; LRT: likelihood ratio test; OR: odds ratio; PCR: polymerase chain reaction; RA: rheumatoid arthritis; SD: standard deviation; SE: shared epitope; SNP: single-nucleotide polymorphism; TDT: transmission disequilibrium test.
###end p 62
###begin title 63
Competing interests
###end title 63
###begin p 64
The authors declare that they have no competing interests.
###end p 64
###begin title 65
Authors' contributions
###end title 65
###begin p 66
HK helped to carry out the molecular genetic studies, performed acquisition of the data, helped to perform analysis and interpretation of the data, and drafted the manuscript. HH and JB helped to carry out the molecular genetic studies. MS, DHe, BP, CP, EP-T, and FC helped to perform analysis and interpretation of the data. DHa and PA helped to perform analysis and interpretation of the data and to draft the manuscript. VHT and UW (and the European Consortium on Rheumatoid Arthritis Families) contributed to the recruitment of families and to the acquisition of clinical data. FE and US helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 66
###begin title 67
Supplementary Material
###end title 67
###begin title 68
Additional data file 1
###end title 68
###begin p 69
###xml 36 45 36 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
A table listing the distribution of HLA-DRB1 alleles in the analyzed RA cohorts.
###end p 69
###begin p 70
Click here for file
###end p 70
###begin title 71
Additional data file 2
###end title 71
###begin p 72
Background information for the conditional logistic regression method applied for family based analysis.
###end p 72
###begin p 73
Click here for file
###end p 73
###begin title 74
Additional data file 3
###end title 74
###begin p 75
A table providing detailed results of conditional logistic regression models of all French families.
###end p 75
###begin p 76
Click here for file
###end p 76
###begin title 77
Additional data file 4
###end title 77
###begin p 78
A table providing detailed results of logistic regression models of the German case control cohort.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Additional data file 5
###end title 80
###begin p 81
A table providing a representation of association analysis in all informative families controlling for LD with DRB1.
###end p 81
###begin p 82
Click here for file
###end p 82
###begin title 83
Acknowledgements
###end title 83
###begin p 84
###xml 933 936 933 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
We are grateful to the RA patients, their families, control individuals, and rheumatologists for participating in this study. We thank Laetitia Michou for previous work in HLA typing and classification of alleles, Jorg Reichhardt for supporting statistical analysis, Knut M Wittkowski for valuable discussion, and Grit Wolfram for expert technical assistance. This project was supported by grants from the German Federal Ministry for Education and Research 'Hochschul-Wissenschafts-Programm' (to PA), the Saechsische Aufbaubank (7692/1187), the European Fund for Regional Development (EFRE 4212/04-04) (to PA), the German Federal Ministry for Education and Research (01KN0702) (to PA and MS), and the German Federal Ministry for Education and Research (0313909) (to HK). This work was also supported by Association Francaise des Polyarthritiques, Association Rhumatisme et Travail, Association Polyarctique, Groupe Taitbout, Genopole(R), Universite Evry-Val d'Essonne, and the European Union (AutoCure).
###end p 84
###begin article-title 85
Genetics of rheumatoid arthritis: is there a pattern predicting extraarticular manifestations?
###end article-title 85
###begin article-title 86
Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility
###end article-title 86
###begin article-title 87
###xml 61 66 <span type="species:ncbi:9606">human</span>
Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis
###end article-title 87
###begin article-title 88
Several regions in the major histocompatibility complex confer risk for anti-CCP- antibody positive rheumatoid arthritis, independent of the DRB1 locus
###end article-title 88
###begin article-title 89
Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis
###end article-title 89
###begin article-title 90
Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis
###end article-title 90
###begin article-title 91
New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility
###end article-title 91
###begin article-title 92
The shared epitope hypothesis in rheumatoid arthritis: Evaluation of alternative classification criteria in a large UK Caucasian cohort
###end article-title 92
###begin article-title 93
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
###end article-title 93
###begin article-title 94
###xml 58 66 <span type="species:ncbi:9606">patients</span>
MICA response to gliadin in intestinal mucosa from celiac patients
###end article-title 94
###begin article-title 95
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis
###end article-title 95
###begin article-title 96
Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis
###end article-title 96
###begin article-title 97
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences
###end article-title 97
###begin article-title 98
MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility
###end article-title 98
###begin article-title 99
Primary association of a MICA allele with protection against rheumatoid arthritis
###end article-title 99
###begin article-title 100
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Association of MICA polymorphism with rheumatoid arthritis patients in Koreans
###end article-title 100
###begin article-title 101
Microsatellite polymorphism of the MICA gene and susceptibility to rheumatoid arthritis
###end article-title 101
###begin article-title 102
Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele
###end article-title 102
###begin article-title 103
Using TESS to predict transcription factor binding sites in DNA sequence
###end article-title 103
###begin article-title 104
###xml 26 31 <span type="species:ncbi:9606">human</span>
Allelic repertoire of the human MHC class I MICA gene
###end article-title 104
###begin article-title 105
Frequency and distribution in three ethnic populations of single nucleotide polymorphisms in the MICA gene
###end article-title 105
###begin article-title 106
Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease
###end article-title 106
###begin article-title 107
Robustness of single-base extension against mismatches at the site of primer attachment in a clinical assay
###end article-title 107
###begin article-title 108
###xml 167 175 <span type="species:ncbi:9606">patients</span>
Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients
###end article-title 108
###begin article-title 109
HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination
###end article-title 109
###begin article-title 110
GenHotel - EA3886 Laboratoire de Recherche Europeen pour la Polyarthrite Rhumatoide
###end article-title 110
###begin article-title 111
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM)
###end article-title 111
###begin article-title 112
MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers
###end article-title 112
###begin article-title 113
StatsDirect Statistical Software
###end article-title 113
###begin article-title 114
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family
###end article-title 114
###begin article-title 115
TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study
###end article-title 115
###begin article-title 116
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 116
###begin article-title 117
Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility
###end article-title 117
###begin article-title 118
###xml 80 85 <span type="species:ncbi:9606">human</span>
SNPeffect v2.0: a new step in investigating the molecular phenotypic effects of human non-synonymous SNPs
###end article-title 118
###begin article-title 119
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo
###end article-title 119
###begin article-title 120
###xml 135 140 <span type="species:ncbi:9606">human</span>
Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival
###end article-title 120
###begin article-title 121
Pregnancy and rheumatic disease: "by the book" or "by the doc"
###end article-title 121
###begin article-title 122
Role for innate immunity in rheumatoid arthritis
###end article-title 122

